![Safety Profile | MENVEO [Meningococcal (Groups A, C, Y and W-135) Oligosaccharide Diphtheria CRM₁₉₇ Conjugate Vaccine]](https://www.menveohcp.com/content/dam/cf-pharma/hcp-menveo/en_US/safety/Safety_chart_Mobile.png "Safety Profile | MENVEO [Meningococcal (Groups A, C, Y and W-135) Oligosaccharide Diphtheria CRM₁₉₇ Conjugate Vaccine]")
Safety Profile | MENVEO [Meningococcal (Groups A, C, Y and W-135) Oligosaccharide Diphtheria CRM₁₉₇ Conjugate Vaccine]
MenACWY-CRM conjugate vaccine booster dose given 4–6 years after priming: Results from a phase IIIb, multicenter, open label study in adolescents and adults - ScienceDirect
In Brief: New Meningococcal Serogroup B Vaccination Recommendations | The Medical Letter Inc.
Menveo vaccination in India: Get vaccinated at home - INVC | INVC
:max_bytes(150000):strip_icc()/Meningococcal-vaccine-5215620_final_05-063b0877ce5c401ca3a0545a27ca6e3c.jpg "Meningococcal Vaccine: Protection, Risk, Schedule")
Meningococcal Vaccine: Protection, Risk, Schedule
Notes from the Field: Administration Error Involving a Meningococcal Conjugate Vaccine — United States, March 1, 2010–September 22, 2015 | MMWR
Menveo II-93 - EPAR
Quadrivalent meningococcal tetanus toxoid-conjugate booster vaccination in adolescents and adults: phase III randomized study | Pediatric Research
Menveo Dosage Guide - Drugs.com
Meningococcal Vaccine Side Effects
Package Insert - MENVEO
Clinical Study Results
Meningococcal Group A C W135 and Y Conjugate Vaccine
![MENVEO (Meningococcal [Groups A,C,Y and W-135] Oligosaccharide Diphtheria CRM197 Conjugate Vaccine) | Home](https://gskpro.com/content/dam/global/hcpportal/en_US/img/menveo/hero-mobile-image.png "MENVEO (Meningococcal [Groups A,C,Y and W-135] Oligosaccharide Diphtheria CRM197 Conjugate Vaccine) | Home")
MENVEO (Meningococcal [Groups A,C,Y and W-135] Oligosaccharide Diphtheria CRM197 Conjugate Vaccine) | Home
ACIP Updates Recommendations for Meningococcal Vaccination | AAFP
![Meningococcal Vaccine | MENVEO [Meningococcal (Groups A, C, Y and W-135) Oligosaccharide Diphtheria CRM₁₉₇ Conjugate Vaccine]](https://www.menveohcp.com/content/dam/cf-pharma/hcp-menveo/en_US/home/time-for-booster-dose-mobile.png "Meningococcal Vaccine | MENVEO [Meningococcal (Groups A, C, Y and W-135) Oligosaccharide Diphtheria CRM₁₉₇ Conjugate Vaccine]")
Meningococcal Vaccine | MENVEO [Meningococcal (Groups A, C, Y and W-135) Oligosaccharide Diphtheria CRM₁₉₇ Conjugate Vaccine]
![Dosing & Administration | MENVEO [Meningococcal (Groups A, C, Y and W-135) Oligosaccharide Diphtheria CRM₁₉₇ Conjugate Vaccine]](https://www.menveohcp.com/content/dam/cf-pharma/hcp-menveo/en_US/dosing/2-vial-presentation-step-1.png "Dosing & Administration | MENVEO [Meningococcal (Groups A, C, Y and W-135) Oligosaccharide Diphtheria CRM₁₉₇ Conjugate Vaccine]")
Dosing & Administration | MENVEO [Meningococcal (Groups A, C, Y and W-135) Oligosaccharide Diphtheria CRM₁₉₇ Conjugate Vaccine]
![Immunogenicity Booster | MENVEO [Meningococcal (Groups A, C, Y and W-135) Oligosaccharide Diphtheria CRM₁₉₇ Conjugate Vaccine]](https://www.menveohcp.com/content/dam/cf-pharma/hcp-menveo/en_US/booster/2-vial-seroresponse-rates-29-days-Mobile.svg "Immunogenicity Booster | MENVEO [Meningococcal (Groups A, C, Y and W-135) Oligosaccharide Diphtheria CRM₁₉₇ Conjugate Vaccine]")
Immunogenicity Booster | MENVEO [Meningococcal (Groups A, C, Y and W-135) Oligosaccharide Diphtheria CRM₁₉₇ Conjugate Vaccine]
PDF) Efficacia e sicurezza dei vaccini quadrivalenti coniugati contro il meningococco disponibili in Italia (Nimenrix® e Menveo®)
Meningococcal Conjugate and Meningococcal B Vaccines
SK bioscience
Recommended Immunization Schedules for Persons Aged 0 Through 18 Years — United States, 2012
![Meningococcal Vaccine | MENVEO [Meningococcal (Groups A, C, Y and W-135) Oligosaccharide Diphtheria CRM₁₉₇ Conjugate Vaccine]](https://www.menveohcp.com/content/dam/cf-pharma/hcp-menveo/en_US/home/time-for-booster-dose.png "Meningococcal Vaccine | MENVEO [Meningococcal (Groups A, C, Y and W-135) Oligosaccharide Diphtheria CRM₁₉₇ Conjugate Vaccine]")
Meningococcal Vaccine | MENVEO [Meningococcal (Groups A, C, Y and W-135) Oligosaccharide Diphtheria CRM₁₉₇ Conjugate Vaccine]
Package Insert - MENVEO
![Dosing & Administration | MENVEO [Meningococcal (Groups A, C, Y and W-135) Oligosaccharide Diphtheria CRM₁₉₇ Conjugate Vaccine]](https://www.menveohcp.com/content/dam/cf-pharma/hcp-menveo/en_US/dosing/2-vial-presentation-step-2.png "Dosing & Administration | MENVEO [Meningococcal (Groups A, C, Y and W-135) Oligosaccharide Diphtheria CRM₁₉₇ Conjugate Vaccine]")
Dosing & Administration | MENVEO [Meningococcal (Groups A, C, Y and W-135) Oligosaccharide Diphtheria CRM₁₉₇ Conjugate Vaccine]
